Close Menu

FNIH

A plasma-based biomarker test for Alzheimer's could serve as a useful initial screen for the disease, as well as provide drugmakers with a way of selecting trial subjects that could be considerably less expensive than current methods like CSF analysis and PET scans.

The university will help an international effort to study the genetics involved in malnutrition.

Snippets: Mar 18, 2009

Premium

Alzheimer's Disease Neuroimaging Initiative, OncoMethylome Sciences, Merck KGaA, 23andMe, Michael J. Fox Foundation for Parkinson's Research, Parkinson's Institute and Clinical Center, and more …

Pages

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.